Cause of death, by non-communicable diseases, ages 0-4, male in Laos
Laos: Cause of death, by non-communicable diseases, ages 0-4, male was 12.2% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 0-4, male in Laos, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 0-4.
Analysis
Laos recorded 12.2% for cause of death, by non-communicable diseases, ages 0-4, male in 2021.
Compared with earlier readings it is down 0.7% on the previous year and up 31.3% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 0-4, male in Laos peaked at 12.8% in 2019 and was at its lowest, 7.4%, in 2000.
That places Laos 139th out of 185 countries with data for 2021, putting it in the bottom quarter.
Cause of death, by non-communicable diseases, ages 0-4, male in Laos, year by year
| Year | % of total male deaths ages 0-4 | Change |
|---|---|---|
| 2000 | 7.4% | — |
| 2010 | 9.3% | +25.6% |
| 2015 | 12.4% | +32.6% |
| 2019 | 12.8% | +3.2% |
| 2020 | 12.3% | -3.4% |
| 2021 | 12.2% | -0.7% |
Laos compared with similar countries
- Laos's 12.2% is above the median for lower middle income countries, which is 12.2%, 1.0× the median. (47 countries reporting)
- Laos's 12.2% is below the median for East Asia & Pacific, which is 31.4%, 39% of the median. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 7.4% | 7.4% | 7.4% | 1 |
| 2010s | 11.5% | 9.3% | 12.8% | 3 |
| 2020s | 12.3% | 12.2% | 12.3% | 2 |
Countries ranked near Laos
More health data for Laos
- Un projection of annual infant deaths, annual growth rate -2.76 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5667 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,260 deaths per 1,000 people (2090)
- Number of infants who die before age 1 317 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 15 (2025)
- Population ages 00-04, female, annual growth rate -0.5161 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0489 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5055 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 0-4, male in Laos?
- Cause of death, by non-communicable diseases, ages 0-4, male in Laos was 12.2% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 0-4, male recorded in Laos?
- The highest recorded value was 12.8% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 0-4, male recorded in Laos?
- The lowest recorded value was 7.4% in 2000.
- How does Laos rank for cause of death, by non-communicable diseases, ages 0-4, male?
- Laos ranks 139th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 0-4, male rising or falling in Laos?
- Over the last ten years it is up 31.3%. The long-run trend across the full record is rising.
- Where does this Laos data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.